NSCLC (Non-small Cell Lung Cancer) Clinical Trials in the UK

NSCLC (Non-small Cell Lung Cancer) Trials in the UK

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a UK site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full UK registry across all sponsors is far larger. UK studies may also be registered separately on ISRCTN.

Narrow the registerReset

Search within results

Recruitment status

Phase

Lead sponsor

Site city

All 6 cities

Target enrolment

Status

Study

Lead sponsor

Phase

Enrol

UK sites

Start

Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NCT06881784NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer, NSCLC, NSCLC (Non-small Cell Lung Carcinoma)

Revolution Medicines, Inc.

Phase 3

590

London, Liverpool, Sutton, Manchester

2025-05-06

Recruiting

Study of XB010 in Subjects With Solid Tumors

NCT06545331Locally Advanced or Metastatic Solid Tumors, Esophageal Squamous Cell Cancer, Head and Neck Squamous Cell Cancer, NSCLC (Non-small Cell Lung Cancer)

Exelixis

Phase 1

396

Leicester, London, Manchester

2024-08-06

Recruiting

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

NCT05873686Advanced Solid Tumor, NSCLC (Non-small Cell Lung Cancer), Renal Cancer, Mesothelioma

Nuvectis Pharma, Inc.

Phase 1

140

Edinburgh, London

2023-10-26

Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a UK investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 17 September 2026. https://priyalifescience.com/clinical-trials-uk/condition/nsclc-non-small-cell-lung-cancer

Query this register directly

GET /api/trials?country=uk&status=recruiting&format=json Try it now →